Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L31 pseudogene 64 (RPL31P64) is one of many genomic pseudogenes related to the ribosomal protein L31 gene (RPL31). Pseudogenes like RPL31P64 are DNA sequences that resemble protein-coding genes but are typically nonfunctional due to mutations that prevent translation or proper function. They are common for ribosomal protein genes, as these genes often have multiple processed pseudogenes dispersed throughout the genome[1][2][3][4]. Pseudogenes are generally not expressed as functional proteins and are not recognized as drug targets, biomarkers, or disease-associated genes. Key point: RPL31P64 is not a functional molecule or a therapeutic target. It is a non-coding pseudogene, and there are no known biological, pharmacological, or clinical roles associated with it[1][2][3][4]. If you intended to refer to the functional ribosomal protein, the canonical protein-coding gene is *RPL31* (ribosomal protein L31), but RPL31P64 specifically refers to a pseudogene, not the active protein[1][2][3][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 64 (RPL31P64).